BeOne Medicines Ltd. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Liang Howard | CFO & Chief Strategy Officer | Sale | 4,100 | $225.24 | $923,484 | 87,800 | Dec 14, 2020 |
| OYLER JOHN | Chief Executive Officer | Gift | 1,591,317 | — | — | 7,336,253 | Dec 11, 2020 |
| Wang Xiaodong | — | Gift | 1,244,542 | — | — | 1,244,542 | Dec 10, 2020 |
| Glazer Donald W. | — | Gift | 589,849 | — | — | 2,907,829 | Dec 4, 2020 |
| Huang Jane | CMO, Hematology | Sale | 100 | $277.22 | $27,722 | 196 | Nov 30, 2020 |
| Huang Jane | CMO, Hematology | Sale | 100 | $301.51 | $30,151 | — | Oct 29, 2020 |
| Wang Xiaodong | — | Sale | 5,000 | $320.00 | $1,600,000 | — | Oct 16, 2020 |
| BAKER FELIX | — | Sale | 125,513 | $220.50 | $27,675,617 | 979,003 | Oct 13, 2020 |
| Wang Xiaodong | — | Sale | 5,000 | $300.00 | $1,500,000 | — | Oct 5, 2020 |
| Wu Xiaobin | President & GM China | Sale | 4,000 | $300.00 | $1,200,000 | — | Oct 5, 2020 |
| Liang Howard | CFO & Chief Strategy Officer | Sale | 500 | $296.47 | $148,235 | 10,700 | Oct 5, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 450 | $272.74 | $122,733 | 22,853 | Sep 29, 2020 |
| Huang Jane | CMO, Hematology | Sale | 730 | $280.65 | $204,874 | 570 | Sep 29, 2020 |
| Wang Xiaodong | — | Sale | 620 | $281.34 | $174,431 | — | Sep 25, 2020 |
| Wu Xiaobin | President & GM China | Sale | 4,000 | $280.35 | $1,121,400 | — | Sep 25, 2020 |
| Wang Xiaodong | — | Sale | 4,916 | $260.26 | $1,279,438 | 84 | Sep 17, 2020 |
| Wu Xiaobin | President & GM China | Sale | 3,500 | $260.20 | $910,700 | 500 | Sep 17, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 600 | $247.01 | $148,206 | 19,139 | Sep 16, 2020 |
| Liang Howard | CFO & Chief Strategy Officer | Option Exercise | 14,000 | $6.50 | $91,000 | 14,000 | Sep 14, 2020 |
| Huang Jane | CMO, Hematology | Sale | 217 | $235.21 | $51,041 | — | Sep 3, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 900 | $239.63 | $215,667 | — | Sep 1, 2020 |
| Huang Jane | CMO, Hematology | Sale | 200 | $240.86 | $48,172 | 2,000 | Aug 28, 2020 |
| AMGEN INC | — | Award / Grant | 59,390 | $248.49 | $14,757,821 | 18,524,373 | Aug 25, 2020 |
| AMGEN INC | — | Award / Grant | 64,176 | $230.18 | $14,772,032 | 18,405,593 | Aug 24, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 3,103 | $237.80 | $737,893 | 37,685 | Aug 21, 2020 |
| AMGEN INC | — | Award / Grant | 64,176 | $234.99 | $15,080,718 | 18,341,417 | Aug 19, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 2,817 | $210.84 | $593,936 | 3,590 | Aug 14, 2020 |
| Chen Timothy Yung-Cheng | — | Sale | 300 | $215.47 | $64,641 | 300 | Aug 10, 2020 |
| Wang Xiaodong | — | Sale | 406 | $216.70 | $87,980 | — | Aug 10, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 3,600 | $221.32 | $796,752 | 11,654 | Aug 5, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 300 | $225.08 | $67,524 | — | Aug 3, 2020 |
| Huang Jane | CMO, Hematology | Option Exercise | 1,500 | $160.40 | $240,600 | 3,000 | Jul 29, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 354 | $246.99 | $87,434 | 100 | Jul 22, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 200 | $254.23 | $50,846 | — | Jul 21, 2020 |
| Wang Xiaodong | — | Sale | 2,039 | $252.61 | $515,072 | 1,379 | Jul 20, 2020 |
| Wu Xiaobin | President & GM China | Sale | 400 | $250.04 | $100,016 | — | Jul 20, 2020 |
| BAKER JULIAN | — | Award / Grant | 13,589,904 | $14.23 | $193,384,334 | 18,840,379 | Jul 15, 2020 |
| AMGEN INC | — | Award / Grant | 29,614,832 | $14.23 | $421,419,059 | 236,249,845 | Jul 15, 2020 |
| Wu Xiaobin | President & GM China | Sale | 200 | $246.10 | $49,220 | — | Jul 15, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 1,501 | $197.80 | $296,898 | 13,792 | Jul 8, 2020 |
| Wang Xiaodong | — | Sale | 6,000 | $200.00 | $1,200,000 | — | Jul 7, 2020 |
| Huang Jane | CMO, Hematology | Sale | 3,921 | $200.00 | $784,200 | — | Jul 7, 2020 |
| Wang Xiaodong | — | Sale | 690 | $189.19 | $130,541 | 4,157 | Jul 1, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 35 | $193.68 | $6,779 | — | Jun 29, 2020 |
| Liang Howard | CFO & Chief Strategy Officer | Sale | 300 | $191.23 | $57,369 | — | Jun 29, 2020 |
| Huang Jane | CMO, Hematology | Sale | 700 | $200.29 | $140,203 | 700 | Jun 26, 2020 |
| OYLER JOHN | Chief Executive Officer | Sale | 3,714 | $182.78 | $678,845 | 32,546 | Jun 23, 2020 |
| Wang Xiaodong | — | Sale | 2,220 | $181.52 | $402,974 | 980 | Jun 23, 2020 |
| Huang Jane | CMO, Hematology | Award / Grant | 48,438 | — | — | 331,902 | Jun 17, 2020 |
| Liang Howard | CFO & Chief Strategy Officer | Award / Grant | 55,887 | — | — | 172,315 | Jun 17, 2020 |